This page is part of the CH VACD (R4) (v4.0.1: STU 4) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
Active as of 2023-12-28 |
<CodeSystem xmlns="http://hl7.org/fhir">
<id value="ch-vacd-allergyintolerance-cs"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p>This case-sensitive code system <code>http://fhir.ch/ig/ch-vacd/CodeSystem/ch-vacd-allergyintolerance-cs</code> defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style="white-space:nowrap">allergyvaccinevarizella<a name="ch-vacd-allergyintolerance-cs-allergyvaccinevarizella"> </a></td><td>Adverse reaction to component of vaccine product containing varicella antigen</td></tr><tr><td style="white-space:nowrap">allergyvaccinehpv<a name="ch-vacd-allergyintolerance-cs-allergyvaccinehpv"> </a></td><td>Adverse reaction to component of vaccine product containing human papillomavirus antigen</td></tr><tr><td style="white-space:nowrap">allergyvaccineherpeszoster<a name="ch-vacd-allergyintolerance-cs-allergyvaccineherpeszoster"> </a></td><td>Adverse reaction to component of vaccine product containing Herpes zoster</td></tr><tr><td style="white-space:nowrap">allergyvaccinefsme<a name="ch-vacd-allergyintolerance-cs-allergyvaccinefsme"> </a></td><td>Adverse reaction to component of vaccine product containing tick-borne encephalitis virus antigen</td></tr></table><p><b>Additional Language Displays</b></p><table class="codes"><tr><td><b>Code</b></td><td><b>Deutsch (Schweiz) (German (Switzerland), de)</b></td><td><b>French (Switzerland) (fr)</b></td><td><b>Italian (Switzerland) (it)</b></td></tr><tr><td>allergyvaccinevarizella</td><td>Unerwünschte Wirkung eines Varizellen-Impfstoffs</td><td>Effet indésirable du vaccin contre la varicelle</td><td>Adverse reaction to component of vaccine product containing varicella antigen</td></tr><tr><td>allergyvaccinehpv</td><td>Unerwünschte Wirkung eines Humanen-Papillomaviren-Impfstoffs</td><td>Effet indésirable du vaccin contre le papillomavirus humain</td><td>Adverse reaction to component of vaccine product containing human papillomavirus antigen</td></tr><tr><td>allergyvaccineherpeszoster</td><td>Unerwünschte Wirkung eines Herpes-Zoster-Impfstoffs</td><td>Effet indésirable du vaccin contre le zona</td><td>Adverse reaction to component of vaccine product containing Herpes zoster</td></tr><tr><td>allergyvaccinefsme</td><td>Unerwünschte Wirkung eines FSME-Impfstoffs</td><td>Effet indésirable du vaccin contre la FSME</td><td>Adverse reaction to component of vaccine product containing tick-borne encephalitis virus antigen</td></tr></table></div>
</text>
<extension
url="http://hl7.org/fhir/StructureDefinition/resource-effectivePeriod">
<valuePeriod>
<start value="2021-01-24T00:00:00+01:00"/>
</valuePeriod>
</extension>
<url
value="http://fhir.ch/ig/ch-vacd/CodeSystem/ch-vacd-allergyintolerance-cs"/>
<identifier>
<use value="official"/>
<system
value="http://fhir.ch/ig/ch-vacd/cs/ch-vacd-allergyintolerance-cs"/>
<value value="ch-vacd-allergyintolerance-cs"/>
</identifier>
<version value="4.0.1"/>
<name value="SwissAllergyIntoleranceCodesystem"/>
<title value="Swiss AllergyIntolerance Codesystem"/>
<status value="active"/>
<experimental value="false"/>
<date value="2023-12-28T11:10:40+01:00"/>
<publisher value="HL7 Switzerland"/>
<contact>
<name value="HL7 Switzerland"/>
<telecom>
<system value="url"/>
<value value="https://www.hl7.ch/"/>
</telecom>
</contact>
<description value="AllergyIntolerance codes in Switzerland."/>
<jurisdiction>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="CHE"/>
</coding>
</jurisdiction>
<copyright value="CC0-1.0"/>
<caseSensitive value="true"/>
<content value="complete"/>
<count value="4"/>
<concept>
<code value="allergyvaccinevarizella"/>
<display
value="Adverse reaction to component of vaccine product containing varicella antigen"/>
<designation>
<language value="de-CH"/>
<value value="Unerwünschte Wirkung eines Varizellen-Impfstoffs"/>
</designation>
<designation>
<language value="fr-CH"/>
<value value="Effet indésirable du vaccin contre la varicelle"/>
</designation>
<designation>
<language value="it-CH"/>
<value
value="Adverse reaction to component of vaccine product containing varicella antigen"/>
</designation>
</concept>
<concept>
<code value="allergyvaccinehpv"/>
<display
value="Adverse reaction to component of vaccine product containing human papillomavirus antigen"/>
<designation>
<language value="de-CH"/>
<value
value="Unerwünschte Wirkung eines Humanen-Papillomaviren-Impfstoffs"/>
</designation>
<designation>
<language value="fr-CH"/>
<value
value="Effet indésirable du vaccin contre le papillomavirus humain"/>
</designation>
<designation>
<language value="it-CH"/>
<value
value="Adverse reaction to component of vaccine product containing human papillomavirus antigen"/>
</designation>
</concept>
<concept>
<code value="allergyvaccineherpeszoster"/>
<display
value="Adverse reaction to component of vaccine product containing Herpes zoster"/>
<designation>
<language value="de-CH"/>
<value value="Unerwünschte Wirkung eines Herpes-Zoster-Impfstoffs"/>
</designation>
<designation>
<language value="fr-CH"/>
<value value="Effet indésirable du vaccin contre le zona"/>
</designation>
<designation>
<language value="it-CH"/>
<value
value="Adverse reaction to component of vaccine product containing Herpes zoster"/>
</designation>
</concept>
<concept>
<code value="allergyvaccinefsme"/>
<display
value="Adverse reaction to component of vaccine product containing tick-borne encephalitis virus antigen"/>
<designation>
<language value="de-CH"/>
<value value="Unerwünschte Wirkung eines FSME-Impfstoffs"/>
</designation>
<designation>
<language value="fr-CH"/>
<value value="Effet indésirable du vaccin contre la FSME"/>
</designation>
<designation>
<language value="it-CH"/>
<value
value="Adverse reaction to component of vaccine product containing tick-borne encephalitis virus antigen"/>
</designation>
</concept>
</CodeSystem>
IG © 2021+ HL7 Switzerland. Package ch.fhir.ig.ch-vacd#4.0.1 based on FHIR 4.0.1. Generated 2023-12-28
Links: Table of Contents |
QA Report
| Propose a change